{"entity":{"id":"nct02843945","kind":"trial","name":"Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source","aka":[],"tldr":"A phase 1/2 trial of Directional Brachytherapy Source Implant in pancreatic ductal adenocarcinoma, run by CivaTech Oncology, now recruiting.","summary":"Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source is a phase 1/2 interventional study registered as NCT02843945 by CivaTech Oncology, with 80 participants planned, started 2017-05-31 and due to reach its primary completion in 2027-10-29. Interventions recorded: Directional Brachytherapy Source Implant.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT02843945","url":"https://clinicaltrials.gov/study/NCT02843945"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["pancreatic","borderline-resectable-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["civatech-oncology"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02843945","phase":"1/2","setting":"Initial Feasibility Study to Evaluate the Safety and Efficacy of the Permanently Implantable LDR CivaSheet® in Combination With External Beam Radiation in the Treatment of Pancreatic Cancer","sponsor":"CivaTech Oncology","participation":[{"nct":"NCT02843945","source":"https://clinicaltrials.gov/study/NCT02843945","fetchedAt":"2026-10-07T16:52:52.489Z","studySha256":"164798f2e5bdfeb65dc1d6e8c0195ed6c5083329443cf9c6c7fd5678463849e8","overallStatus":"RECRUITING","lastUpdatePosted":"2025-06-17","leadSponsor":"CivaTech Oncology","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":80,"enrolmentType":"ESTIMATED","siteCount":6,"recruitingSiteCount":1,"countries":["United States"]}],"started":"2017-05-31","startedType":"actual","enrolled":80,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02843945/","neighbours":{"cancer":[{"id":"borderline-resectable-pdac","kind":"cancer","name":"Borderline resectable pancreatic ductal adenocarcinoma","route":"/cancers/borderline-resectable-pdac/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"company":[{"id":"civatech-oncology","kind":"company","name":"CivaTech Oncology","route":"/companies/civatech-oncology/"}]}}